Home Page Home Article Read Close close

Original article by CARLO RATTO
Department of Surgery Catholic University Rome, Italy

Sacral neuromodulation in the treatment of fecal incontinence. The GINS experience.



TABLE 1. – Results of QoL evaluation (Rockwood’s questionnaire) and of health status (SF-36), basal and in the follow up (median: 12 months;
range: 7-84 months) after Permanent implantation of SNM for FI.

 

Total Cases

Idiopathic Neuropathy

Jatrogenic Sphincter Damage

Rectal Resection

basal

FU

basal

FU

basal

FU

basal

FU

Physical Dominion

2.1a

2.9 a

2.2 b

2.8 b

2.2 d

3.1 d

1.7 f

2.8 f

Psychological Dominion

1.5 a

2.7 a

1.5 b

2.6 b

1.5 e

2.9 e

1.1 g

2.8 g

Social Dominion

2.2 a

2.9 a

2.2 c

2.7 c

2.2

3.0

2.1 g

3.0 g

Physical Function

57.0 h

68.7 h

51.2

62.5

68.8

75.8

56.3 c

78.3 c

Physical Role

28.9 h

56.7 h

19.6 c

48.2 c

53.1

59.4

5.0 l

85.0 l

Physical Pain

57.5

65.0

56.7

64.8

52.4

64.6

62.2

77.3

Health General Status

37.9 i

48.4 i

30.1 c

46.3 c

54.0

53.1

24.5

50.2

Vitality

41.7 c

53.9 c

35.7

48.3

54.3

62.4

35.0 g

56.7 g

Social Function

45.1 h

61.7 h

4.0 h

64.1 h

56.3

62.5

33.3 g

62.5 g

Emotional Role

29.0 b

58.1 b

26.2

38.1

37.5 c

70.8 c

11.1 m

88.9 m

Mental Health

45.4 e

61.8 e

40.5 g

62.1 g

55.4

58.0

34.0 n

66.7 n

a p<0.0001; b p<0.002; c p<0.02; d p=0.004; e p=0.006; f p=0.009; g p<0.03; h p=0.008; i p<0.04; l p=0.001; m p=0.005; n p<0.06. 



Close close